Yi-Wei Wang

Overexpressed‐eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma

Y. Jou, P. Tu, De-Leung Gu, 2013, Hepatology.

Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models

Yuan Zhang, Shengping Yuan, Lei Zhou, 2022, Frontiers in Aging Neuroscience.

Enucleation combined with guided bone regeneration in small and medium-sized odontogenic jaw cysts

Yi-Wei Wang, Qingguo Gu, Yi-Ting Cao, 2022, World journal of clinical cases.

A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis

T. Chou, Y. Jou, Y. Yeh, 2022, Journal of Biomedical Science.

> Replace This Line with Your Paper Identification Number (double-click Here to Edit) <

S. Lam, Z. Xuan, I. Wistuba, 2022 .

Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.

Y. Jou, J. Ko, P. Tu, 2011, Neoplasia.

DNA methylation data analysis and its application to cancer research.

Michael Q. Zhang, Xiaotu Ma, Michael Q Zhang, 2013, Epigenomics.

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers

Michael Q. Zhang, Yang Xie, Xiaotu Ma, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy

C. Chen, Y. Jou, Wen-Hui Su, 2012, Clinical Cancer Research.

ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers

S. Lam, L. Girard, A. Gazdar, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cancer Therapy : Preclinical HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identi fi cation of Low Toxicity Modalities for Combination Cancer Therapy

C. Chen, Y. Jou, Wen-Hui Su, 2012 .

SCT promoter methylation is a highly discriminative biomarker for lung and many other cancers

S. Lam, I. Wistuba, L. Girard, 2015, bioRxiv.